Shiga toxin-producing haemolytic uraemic syndrome (STEC-HUS): diagnosis, surveillance and public-health management in England.
作者信息
Jenkins Claire, Byrne Lisa, Vishram Bhavita, Sawyer Clare, Balasegaram Sooria, Ahyow Laura, Johnson Sally
机构信息
National Infection Service, Public Health England, London NW9 5HT, UK.
Public Health Wales, Cardiff CF10 4BZ, UK.
出版信息
J Med Microbiol. 2020 Jul;69(7):1034-1036. doi: 10.1099/jmm.0.001215.
Abstract
摘要
相似文献
1
Shiga toxin-producing haemolytic uraemic syndrome (STEC-HUS): diagnosis, surveillance and public-health management in England.产志贺毒素溶血尿毒综合征（STEC-HUS）：英格兰的诊断、监测与公共卫生管理
J Med Microbiol. 2020 Jul;69(7):1034-1036. doi: 10.1099/jmm.0.001215.
2
Bloody Diarrhea and Shiga Toxin-Producing Escherichia coli Hemolytic Uremic Syndrome in Children: Data from the ItalKid-HUS Network.儿童血性腹泻和产志贺毒素大肠埃希菌溶血尿毒症综合征：来自 ItalKid-HUS 网络的数据。
J Pediatr. 2021 Oct;237:34-40.e1. doi: 10.1016/j.jpeds.2021.06.048. Epub 2021 Jun 29.
3
Paediatric haemolytic uraemic syndrome related to Shiga toxin-producing , an overview of 10 years of surveillance in France, 2007 to 2016.小儿溶血尿毒综合征与产志贺毒素大肠埃希菌相关：法国 2007 至 2016 年十年监测概述。
Euro Surveill. 2019 Feb;24(8). doi: 10.2807/1560-7917.ES.2019.24.8.1800068.
4
The epidemiology of Shiga toxin-producing Escherichia coli infections in the South East of England: November 2013-March 2017 and significance for clinical and public health.英国东南部产志贺毒素大肠杆菌感染的流行病学：2013 年 11 月至 2017 年 3 月及对临床和公共卫生的意义。
J Med Microbiol. 2019 Jun;68(6):930-939. doi: 10.1099/jmm.0.000970. Epub 2019 Apr 17.
5
Antibody response to lipopolysaccharides and recombinant proteins of Shiga toxin (STX)-producing Escherichia coli (STEC) in children with haemolytic uraemic syndrome in Poland.波兰溶血尿毒综合征患儿对产志贺毒素大肠杆菌（STEC）脂多糖和重组蛋白的抗体反应。
Lett Appl Microbiol. 2020 Jun;70(6):440-446. doi: 10.1111/lam.13295. Epub 2020 Apr 28.
6
Estimating true incidence of O157 and non-O157 Shiga toxin-producing Escherichia coli illness in Germany based on notification data of haemolytic uraemic syndrome.基于溶血性尿毒综合征的报告数据估算德国O157和非O157产志贺毒素大肠杆菌疾病的真实发病率。
Epidemiol Infect. 2016 Nov;144(15):3305-3315. doi: 10.1017/S0950268816001436. Epub 2016 Jul 29.
7
Recurrent seasonal outbreak of an emerging serotype of Shiga toxin-producing Escherichia coli (STEC O55:H7 Stx2a) in the south west of England, July 2014 to September 2015.2014年7月至2015年9月，英格兰西南部出现产志贺毒素大肠杆菌（STEC O55:H7 Stx2a）新血清型的季节性反复暴发。
Euro Surveill. 2017 Sep 7;22(36). doi: 10.2807/1560-7917.ES.2017.22.36.30610.
8
encoding Shiga toxin subtype Stx2f causing human infections in England, 2015-2022.2015-2022 年在英格兰引起人类感染的编码志贺毒素亚型 Stx2f。
J Med Microbiol. 2023 Jun;72(6). doi: 10.1099/jmm.0.001707.
9
Eculizumab in the treatment of Shiga toxin haemolytic uraemic syndrome.依库珠单抗治疗志贺毒素溶血尿毒综合征。
Pediatr Nephrol. 2019 Sep;34(9):1485-1492. doi: 10.1007/s00467-018-4025-0. Epub 2018 Jul 30.
10
Epidemiological investigation of recurrent outbreaks of haemolytic uraemic syndrome caused by Shiga toxin-producing serotype O55:H7 in England, 2014-2018.2014-2018 年在英国由产志贺毒素血清型 O55：H7 引起的溶血性尿毒综合征反复暴发的流行病学调查。
Epidemiol Infect. 2021 Apr 19;149:e108. doi: 10.1017/S0950268821000844.
引用本文的文献
1
Shiga toxin-producing illness in Aotearoa | New Zealand, 2016-2022: epidemiological, genomic and traditional typing analyses provide insight into a significant endemic disease while highlighting knowledge gaps.2016 - 2022年新西兰奥塔哥地区产志贺毒素疾病：流行病学、基因组学和传统分型分析为一种重要的地方病提供了见解，同时凸显了知识空白。
Front Microbiol. 2025 Jul 2;16:1605469. doi: 10.3389/fmicb.2025.1605469. eCollection 2025.
2
Development of a set of bacterial engineered glycoconjugates as novel serogroup-specific antigens for the serodiagnosis of Escherichia coli O26, O111, O103 and O45 infections associated to hemolytic uremic syndrome.开发一组细菌工程化糖缀合物作为新型血清群特异性抗原，用于与溶血尿毒综合征相关的大肠杆菌O26、O111、O103和O45感染的血清学诊断。
Microb Cell Fact. 2025 May 20;24(1):116. doi: 10.1186/s12934-025-02694-0.
3
Long-term health outcomes of Shiga toxin-producing Escherichia coli O157 (STEC O157) infection and STEC-associated haemolytic uraemic syndrome (STEC-HUS), Wales, 1990-2020.1990 - 2020年威尔士产志贺毒素大肠杆菌O157（STEC O157）感染及STEC相关溶血尿毒综合征（STEC - HUS）的长期健康结局
Pediatr Nephrol. 2025 Feb 4. doi: 10.1007/s00467-024-06640-x.
4
An outbreak of Shiga toxin-producing serotype O103:H2 associated with unpasteurized soft cheese, England and Wales, 2022.2022年，英格兰和威尔士发生与未巴氏杀菌软奶酪相关的产志贺毒素血清型O103:H2疫情。
Epidemiol Infect. 2025 Jan 22;152:e172. doi: 10.1017/S0950268824001523.
5
Genomic analysis of an outbreak of Shiga toxin-producing O183:H18 in the United Kingdom, 2023.2023 年英国爆发的产志贺毒素 O183:H18 疫情的基因组分析。
Microb Genom. 2024 May;10(5). doi: 10.1099/mgen.0.001243.
6
How We Interpret Thrombosis with Thrombocytopenia Syndrome?我们如何解读血栓性血小板减少性紫癜？
Int J Mol Sci. 2024 May 1;25(9):4956. doi: 10.3390/ijms25094956.
7
Haemolytic uraemic syndrome in children England, Wales, Northern Ireland, and Ireland: A prospective cohort study.儿童溶血尿毒综合征：英格兰、威尔士、北爱尔兰和爱尔兰的前瞻性队列研究。
Epidemiol Infect. 2023 Sep 1;151:e160. doi: 10.1017/S0950268823001413.
8
Diagnosis and Treatment for Shiga Toxin-Producing Associated Hemolytic Uremic Syndrome.产志贺样毒素大肠埃希菌相关性溶血尿毒综合征的诊断与治疗。
Toxins (Basel). 2022 Dec 23;15(1):10. doi: 10.3390/toxins15010010.
9
Outbreak of STEC O157:H7 linked to a milk pasteurisation failure at a dairy farm in England, 2019.2019 年英格兰一家奶牛场的牛奶巴氏消毒失败导致 STEC O157:H7 爆发。
Epidemiol Infect. 2022 May 18;150:e114. doi: 10.1017/S0950268822000929.
10
Epidemiological investigations identified an outbreak of Shiga toxin-producing serotype O26:H11 associated with pre-packed sandwiches.流行病学调查发现了一起与预包装三明治有关的产志贺毒素血清型 O26:H11 爆发。
Epidemiol Infect. 2021 Aug 10;149:e178. doi: 10.1017/S0950268821001576.
本文引用的文献
1
Antimicrobial resistance in Shiga toxin-producing other than serotype O157 : H7 in England, 2014-2016.2014-2016 年英格兰产志贺毒素的非 O157：H7 型其他血清型大肠埃希菌中的抗微生物药物耐药性。
J Med Microbiol. 2020 Mar;69(3):379-386. doi: 10.1099/jmm.0.001146.
2
Evaluation of chromogenic selective agar (CHROMagar STEC) for the direct detection of Shiga toxin-producing from faecal specimens.显色选择性琼脂（CHROMagar STEC）用于直接检测粪便标本中产志贺毒素的评估。
J Med Microbiol. 2020 Mar;69(3):487-491. doi: 10.1099/jmm.0.001136.
3
Recurrent seasonal outbreak of an emerging serotype of Shiga toxin-producing Escherichia coli (STEC O55:H7 Stx2a) in the south west of England, July 2014 to September 2015.2014年7月至2015年9月，英格兰西南部出现产志贺毒素大肠杆菌（STEC O55:H7 Stx2a）新血清型的季节性反复暴发。
Euro Surveill. 2017 Sep 7;22(36). doi: 10.2807/1560-7917.ES.2017.22.36.30610.
4
Enteropathogen detection in children with diarrhoea, or vomiting, or both, comparing rectal flocked swabs with stool specimens: an outpatient cohort study.比较直肠拭子与粪便标本在腹泻、呕吐或两者兼有患儿中检测肠道病原体：一项门诊队列研究。
Lancet Gastroenterol Hepatol. 2017 Sep;2(9):662-669. doi: 10.1016/S2468-1253(17)30160-7. Epub 2017 Jul 14.
5
High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine.尽管接受了脑膜炎球菌疫苗，但接受依库珠单抗（Soliris）治疗的患者仍有患侵袭性脑膜炎球菌病的高风险。
MMWR Morb Mortal Wkly Rep. 2017 Jul 14;66(27):734-737. doi: 10.15585/mmwr.mm6627e1.
6
Use of the EntericBio Gastro Panel II in a diagnostic microbiology laboratory: challenges and opportunities.在诊断微生物学实验室中使用肠道生物胃肠检测板II：挑战与机遇
Pathology. 2017 Jun;49(4):419-422. doi: 10.1016/j.pathol.2017.02.003. Epub 2017 Apr 21.
7
Early Volume Expansion and Outcomes of Hemolytic Uremic Syndrome.早期容量扩张与溶血尿毒综合征的预后
Pediatrics. 2016 Jan;137(1). doi: 10.1542/peds.2015-2153. Epub 2015 Dec 7.
8
The epidemiology, microbiology and clinical impact of Shiga toxin-producing Escherichia coli in England, 2009-2012.2009 - 2012年英国产志贺毒素大肠杆菌的流行病学、微生物学及临床影响
Epidemiol Infect. 2015 Dec;143(16):3475-87. doi: 10.1017/S0950268815000746. Epub 2015 Apr 29.
9
Management of hemolytic uremic syndrome.溶血尿毒综合征的管理
F1000Prime Rep. 2014 Dec 1;6:119. doi: 10.12703/P6-119. eCollection 2014.
10
Epidemiology and microbiology of Shiga toxin-producing Escherichia coli other than serogroup O157 in England, 2009-2013.2009-2013 年英格兰产志贺毒素大肠杆菌非 O157 血清群的流行病学和微生物学。
J Med Microbiol. 2014 Sep;63(Pt 9):1181-1188. doi: 10.1099/jmm.0.075895-0. Epub 2014 Jun 13.
Zotero 插件